| | Editorial Mapping the Future of Neuro-Oncology W. K. Alfred Yung and C. David James Neuro-oncol. 2007 January; 9(1): 1–2. doi: 10.1215/15228517-2006-027.PMCID: PMC1828102 Basic and Translational Investigations CXCR4 and SDF1 expression in human meningiomas: A proliferative role in tumoral meningothelial cells in vitro Adriana Bajetto, Federica Barbieri, Alessandra Pattarozzi, Alessandra Dorcaratto, Carola Porcile, Jean Louis Ravetti, Gianluigi Zona, Renato Spaziante, Gennaro Schettini, and Tullio Florio Neuro-oncol. 2007 January; 9(1): 3–11. doi: 10.1215/15228517-2006-023.PMCID: PMC1828107 Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol) William J. Bodell, Alexander P. Bodell, and Donald D. Giannini Neuro-oncol. 2007 January; 9(1): 12–19. doi: 10.1215/15228517-2006-014.PMCID: PMC1828109 Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts Yoji Yamashita, Michal T. Krauze, Tomohiro Kawaguchi, Charles O. Noble, Daryl C. Drummond, John W. Park, and Krystof S. Bankiewicz Neuro-oncol. 2007 January; 9(1): 20–28. doi: 10.1215/15228517-2006-016.PMCID: PMC1828110 Clinical Investigations The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme Karla V. Ballman, Jan C. Buckner, Paul D. Brown, Caterina Giannini, Patrick J. Flynn, Betsy R. LaPlant, and Kurt A. Jaeckle Neuro-oncol. 2007 January; 9(1): 29–38. doi: 10.1215/15228517-2006-025.PMCID: PMC1828103 Successful treatment of childhood intramedullary spinal cord astrocytomas with irinotecan and cisplatin Jaume Mora, Ofelia Cruz, Sandra Gala, and Ramon Navarro Neuro-oncol. 2007 January; 9(1): 39–46. doi: 10.1215/15228517-2006-026.PMCID: PMC1828108 The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas David E. Gerber, Stuart A. Grossman, Michel Zeltzman, Michele A. Parisi, and Lawrence Kleinberg Neuro-oncol. 2007 January; 9(1): 47–52. doi: 10.1215/15228517-2006-024.PMCID: PMC1828105 The course of neurocognitive functioning in high-grade glioma patients Ingeborg Bosma, Maaike J. Vos, Jan J. Heimans, Martin J.B. Taphoorn, Neil K. Aaronson, Tjeerd J. Postma, Henk M. van der Ploeg, Martin Muller, W. Peter Vandertop, Ben. J. Slotman, and Martin Klein Neuro-oncol. 2007 January; 9(1): 53–62. doi: 10.1215/15228517-2006-012.PMCID: PMC1828106 Preoperative estimation of residual volume for WHO grade II glioma resected with intraoperative functional mapping Emmanuel Mandonnet, Saad Jbabdi, Luc Taillandier, Damien Galanaud, Habib Benali, Laurent Capelle, and Hugues Duffau Neuro-oncol. 2007 January; 9(1): 63–69. doi: 10.1215/15228517-2006-015.PMCID: PMC1828101 Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme Michael A. Badruddoja, Kara Penne, Annick Desjardins, David A. Reardon, Jeremy N. Rich, Jennifer A. Quinn, Sith Sathornsumetee, Allan H. Friedman, Darell D. Bigner, James E. Herndon, II, Ann Cahill, Henry S. Friedman, and James J. Vredenburgh Neuro-oncol. 2007 January; 9(1): 70–74. doi: 10.1215/15228517-2006-022.PMCID: PMC1828104 Case Study Hypersomnia as presenting symptom of anti-Ma2-associated encephalitis: Case study Iñigo Rojas-Marcos, Francesc Graus, Gema Sanz, Arturo Robledo, and Carlos Diaz-Espejo Neuro-oncol. 2007 January; 9(1): 75–77. doi: 10.1215/15228517-2006-013.PMCID: PMC1828100 Society News SOCIETY NEWS Oliver Bögler Neuro-oncol. 2007 January; 9(1): 78–79. doi: 10.1215/15228517-2006-028.PMCID: PMC1828099 |